查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1378556

Crispr 和 Cas Gene 市場：按產品類型、按應用、按最終用戶、按地區

Crispr and Cas Gene Market, By Product Type, By Application, By End User, By Region
出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2023年，全球 Crispr 和 Cas 基因市場將達到 15.4 億美元，預計在預測期內（2023-2030年）CAGR為 22.8%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 15.4億美元
實績資料 2018-2021 預測期 2023-2030
預測期CAGR 22.80% 2030年市場規模預測 64.7億美元
圖 1. Crispr 和 Cas 基因的全球市場佔有率（%）（依產品類型），2023年
Crispr 和 Cas 基因市場-IMG1

CRISPR為常間回文重複序列叢集。 CRISPR 是將細菌免疫系統的 DNA 切割元件轉化為基因編輯工具。該系統的兩個關鍵組件是引導 Cas 核酸酶到達其標靶的引導 RNA 序列（gRNA）和結合並切割 DNA 的 CRISPR 相關（Cas）核酸酶。 CRISPR 是在細菌的免疫系統中發現的，它可以讓噬菌體切割和破壞入侵病毒的 DNA。在其 DNA 切割能力的分子基礎被確定後，CRISPR 迅速發展成為編輯基因組的工具。 CRISPR 很重要，因為它允許研究人員改變幾乎任何生物體的遺傳密碼。與先前的基因編輯方法相比，CRISPR更簡單、更便宜、更準確。它還具有多種實際應用，例如開發耐旱作物和糾正遺傳疾病。在細菌和古細菌中，適應性免疫是基於 CRISPR 系統。細菌和古細菌的適應性免疫是基於 CRISPR 系統。 CRISPR 系統利用 Cas 核酸酶，即與 DNA 結合併導致雙鏈（DSB）的酵素。當病毒感染細菌時，原型間隔區（病毒 DNA 的片段）會被 Cas 核酸酶切割。該片段與先前感染的病毒的其他片段一起作為免疫記憶儲存在細菌基因組中。將這些病毒間隔片段置於重複序列之間的間隔序列和回文重複序列賦予了 CRISPR 名稱。

市場動態

Crispr 和 CAS 基因市場的主要參與者致力於開發創新產品，預計這將在預測期內推動市場成長。例如，2023年 2月 8 日，生物技術公司 Vertex Therapeutics 向美國食品藥物管理局（FDA）申請了第一個基於 CRISPR 的基因編輯療法。

本研究的主要特點

  • 本報告詳細分析了全球CRISPR和CAS基因市場，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR）。
  • 它還闡明了不同細分市場的潛在收益成長機會，並說明了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 這份研究報告根據公司亮點、產品系列、主要成就、財務實績和策略等參數，介紹了全球 Crispr 和 Cas 基因市場的主要企業。
  • 本研究涵蓋的主要企業包括 Thermo Fisher Scientific Inc.、Merck KGaA（Sigma-Aldrich）、OriGene Technologies, Inc.、New England Biolabs、Cellecta, Inc.、Agilent Technologies, Inc. 和 Applied StemCell, Inc.. Synthego、 Genscript、Mirus Bio LLC、Integrated DNA Technologies, Inc. 和Mammoth Biosciences, Inc.
  • 本報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
  • 本報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過分析全球 Crispr 和 Cas Gene 市場時所使用的各種策略矩陣來促進決策。

目錄

第1章 調查目的和假設

  • 這項研究的目的
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章 市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • 最近的趨勢
  • 合併、收購和合作
  • 監管場景
  • 主要進展
  • PEST分析
  • 波特的分析

第4章 全球 Crispr 和 Cas 基因市場 - COVID-19 疾病的影響分析

  • 經濟影響
  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 對需求和供給的影響

第5章 全球 Crispr 和 Cas Gene 市場，依產品類型，2018-2030年

  • 基於向量的Cas
  • 無 DNA 鈣
  • 其他

第6章 全球 Crispr 和 Cas Gene 市場，依應用分類，2018-2030年

  • 基因組工程
  • 疾病模型
  • 功能基因體學
  • 減弱/活化
  • 其他

第7章 全球 Crispr 和 Cas Gene 市場，依最終用戶分類，2018-2030年

  • 生物技術和製藥公司
  • 學術和政府研究機構
  • 合約研究組織

第8章 2018-2030年全球Crispr和Cas Gene市場（依地區）

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 競爭形勢

  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • Merck KGaA（Sigma-Aldrich）
    • OriGene Technologies, Inc.
    • New England Biolabs
    • Cellecta, Inc.
    • Agilent Technologies
    • Applied StemCell, Inc.
    • Synthego
    • Genscript
    • Mirus Bio LLC
    • Integrated DNA Technologies, Inc.
    • Mammoth Biosciences, Inc.
    • Analysts'Views

第10章 章節

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI2598

The global crispr and cas gene market is estimated to be valued at US$ 1.54 Billion in 2023 and is expected to exhibit a CAGR of 22.8 % during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 1.54 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 22.80% 2030 Value Projection: US$ 6.47 Bn
Figure 1. Global Crispr and Cas Gene Market Share (%), By Product Type, 2023
Crispr and Cas Gene Market - IMG1

Clustered Regularly Interspaced Short Palindromic Repeats is known as CRISPR. It is a DNA-chopping element of bacterial immune systems that has been transformed into a gene editing tool. By following a configurable guide, it functions as a precise pair of molecular scissors that can cut a target DNA sequence.

A guide RNA sequence (gRNA), which leads the Cas nuclease to its target, and a CRISPR-associated (Cas) nuclease, which binds and breaks DNA, are the two essential components of the system. It was found in bacterial immune systems, where it destroys bacteriophage-invading viruses-by chopping off their DNA. It was swiftly created as a tool for editing genomes after the molecular basis for its DNA-cleaving ability was identified.

CRISPR is significant because it enables researchers to change practically any organism's genetic coding. In comparison to earlier gene editing methods, it is easier, less expensive, and more accurate. It also has a variety of practical applications, including as developing crops that can withstand drought and correcting genetic diseases.

In bacteria and archaea, adaptive immunity is based on the CRISPR system. It makes use of Cas nucleases, enzymes that can attach to DNA and cause double-stranded breaks (DSBs). A protospacer, a segment of viral DNA, gets cut off by the Cas nuclease when a virus infects a bacteria. This fragment, along with others from earlier infected viruses, is kept in the bacterial genome as an immunological memory. The arrangement of spacers and palindromic repeats that results in the placement of these viral spacer pieces between repetitive sequences is what gives CRISPR its name.

Market Dynamics

The key players in the crispr and cas gene market are focusing on the development of innovative products is expected to propel the market growth over the forecast period. For instance, on February 8, 2023, Vertex Therapeutics, a biotechnology company, submitted its first CRISPR-based gene editing therapy to the U.S. Food and Drug Administration (FDA).

Key features of the study:

  • This report provides an in-depth analysis of the global crispr and cas gene market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • The study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global crispr and cas gene market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA (Sigma-Aldrich), OriGene Technologies, Inc., New England Biolabs, Cellecta, Inc., Agilent Technologies, Inc., Applied StemCell, Inc., Synthego, Genscript, Mirus Bio LLC, Integrated DNA Technologies, Inc., and Mammoth Biosciences, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global crispr and cas gene market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global crispr and cas gene market

Global Crispr and Cas Gene Market Detailed Segmentation:

  • By Product Type:
    • Vector-based Cas
    • DNA-free Cas
    • Others
  • By Application:
    • Genome Engineering
    • Disease Models
    • Functional Genomics
    • Knockdown/Activation
    • Others
  • By End User:
    • Biotechnology and Pharmaceutical Companies
    • Academic & Government Research Institutes
    • Contract Research Organizations
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Thermo Fisher Scientific Inc.
    • Merck KGaA (Sigma-Aldrich)
    • OriGene Technologies, Inc.
    • New England Biolabs
    • Cellecta, Inc.
    • Agilent Technologies
    • Applied StemCell, Inc
    • Synthego
    • Genscript
    • Mirus Bio LLC
    • Integrated DNA Technologies, Inc.
    • Mammoth Biosciences, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Recent Trends
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis
  • PORTER's Analysis

4. Global Crispr And Cas Gene Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Crispr And Cas Gene Market, By Product Type, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Vector-based Cas
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • DNA-free Cas
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends

6. Global Crispr And Cas Gene Market, By Application, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Genome Engineering
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Disease Models
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Functional Genomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Knockdown/Activation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Segment Trends

7. Global Crispr And Cas Gene Market, By End User, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Biotechnology and Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Academic & Government Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Contract Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

8. Global Crispr And Cas Gene Market, By Region, 2018 - 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • North America
    • Market Size and Forecast, Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth, By Application, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth, By End User, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Market Size and Forecast, Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth, By Application, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth, By End User, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth, By Application, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth, By End User, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Market Size and Forecast, Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth, By Application, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth, By End User, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Market Size and Forecast, Y-o-Y Growth, By Product Type, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth, By Application, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth, By End User, 2018 - 2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth, By Country/Region, 2018 -2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Company Profiles
    • Thermo Fisher Scientific Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Merck KGaA (Sigma-Aldrich)
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • OriGene Technologies, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • New England Biolabs
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Cellecta, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Agilent Technologies
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Applied StemCell, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Synthego
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Genscript
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Mirus Bio LLC
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Integrated DNA Technologies, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Mammoth Biosciences, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Analysts' Views

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact